1. What is the projected Compound Annual Growth Rate (CAGR) of the Infectious Disease Point-of-care (POC) Diagnostics Market?
The projected CAGR is approximately 6.5%.
Infectious Disease Point-of-care (POC) Diagnostics MarketInfectious Disease Point-of-care (POC) Diagnostics Market Report Probes the USD Billion Size, Share, Growth Report and Future Analysis by 2033
Infectious Disease Point-of-care (POC) Diagnostics Market by Technique (Lateral Flow Immunoassay, Agglutination Test, Others), by Disease (HIV, Hepatitis B Virus, Pneumonia/Streptococcus Associated Infections, RSV, Influenza, Clostridium Difficile Infections, Hepatitis C Virus, Methicillin-Resistant Staphylococcus Aureus, Tuberculosis, Others), by Disease, COVID-19 Point-of-care (POC), by End User (Hospital Bedside, Physicians Office Lab, Urgent Care & Retail Clinics, Others), by By Geography (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) Forecast 2025-2033
Base Year: 2024
180 Pages
Infectious Disease Point-of-care (POC) Diagnostics Market Report Probes the USD Billion Size, Share, Growth Report and Future Analysis by 2033
Infectious Disease Point-of-care (POC) Diagnostics Market Report Probes the USD Billion Size, Share, Growth Report and Future Analysis by 2033
Key Insights
The Infectious Disease Point-of-care (POC) Diagnostics Market size was valued at USD 15.81 USD Billion in 2023 and is projected to reach USD 24.57 USD Billion by 2032, exhibiting a CAGR of 6.5 % during the forecast period. Infectious Disease POC (Point-of-care) Diagnostics is an approach to test exhilaration rapidly and precisely that can be performed anywhere at the site of an infection. They vary depending on their target, application, and assay type including nucleic acid amplification tests (NAATs), immunoassays, and molecular assays. As NAATs detect the genetic material of pathogens, immunoassays define the presence of different types of antibodies or antigens by the immune system. DNA and RNA detection is based on the molecular method of PCR, which includes amplification and discovery. POC diagnostics provide benefits such as easy access, transportability, and fast results placing them among the few most useful diagnostic tools in resource-limited counties, emergency departments, and the remotest of areas. They enable early diagnosis, health monitoring, and outbreak control procedures as well as ensure patient care without the need of lab facilities which are often lack in certain places.
-Diagnostics-Market.png)
Infectious Disease Point-of-care (POC) Diagnostics Trends
- Increasing prevalence of infectious diseases
- Growing demand for rapid and accurate diagnostics
- Technological advancements in POC devices
- Rising awareness of POC diagnostics
- Government initiatives to promote POC diagnostics
Driving Forces: What's Propelling the Infectious Disease Point-of-care (POC) Diagnostics Market
- Urgent Need for Rapid and Accurate Diagnostics: The demand for immediate diagnostic information is paramount in managing infectious disease outbreaks and improving patient outcomes. Point-of-care (POC) diagnostics offer real-time or near-patient results, enabling prompt diagnosis, treatment initiation, and effective disease control, minimizing transmission and mortality rates. This is especially crucial in resource-limited settings where rapid access to sophisticated laboratory facilities is unavailable.
- Surging Prevalence of Infectious Diseases: The global landscape is facing a complex challenge with the persistent threat of established infectious diseases and the continuous emergence of novel pathogens, including antimicrobial-resistant strains. This escalating prevalence necessitates efficient and accessible diagnostic tools for effective public health management and personalized patient care. Factors like climate change, globalization, and antibiotic resistance are further exacerbating this trend.
- Breakthrough Technological Advancements: Significant strides in various technologies are revolutionizing POC diagnostics. Microfluidics enables miniaturization and automation, while advancements in biosensors offer enhanced sensitivity and specificity. Molecular diagnostic techniques, such as PCR and isothermal amplification, provide rapid and accurate detection of pathogens. These technological leaps are driving the development of more portable, user-friendly, and cost-effective POC devices.
- Improved Connectivity and Data Integration: The seamless integration of POC devices with electronic health records (EHRs), telemedicine platforms, and public health surveillance systems is transforming disease management. Real-time data sharing facilitates rapid response to outbreaks, enables remote patient monitoring, and supports informed decision-making at both the individual and population levels. This improved data flow contributes to more effective public health interventions and disease control strategies.
- Increased Investment and Funding: Government initiatives, private sector investments, and philanthropic funding are increasingly directed towards the development and deployment of innovative POC diagnostic solutions. This financial support fuels research and development, promotes market expansion, and enhances accessibility to these critical tools, particularly in underserved regions.
Challenges and Restraints in Infectious Disease Point-of-care (POC) Diagnostics Market
- Lack of skilled professionals: Implementing POC diagnostics requires trained personnel, which may be limited in certain regions.
- Limited sensitivity and specificity: Some POC devices may have lower sensitivity and specificity compared to laboratory-based tests.
- Regulatory hurdles: Stringent regulatory requirements can delay the approval and commercialization of POC devices.
Emerging Trends in Infectious Disease Point-of-care (POC) Diagnostics
- Telemedicine and POC diagnostics: Integrating telemedicine with POC diagnostics allows for remote patient monitoring and diagnosis.
- Multiplex POC tests: These tests can simultaneously detect multiple pathogens, providing broader diagnostic information.
Growth Catalysts in Infectious Disease Point-of-care (POC) Diagnostics Industry
-Diagnostics-Market.png)
- Collaboration with healthcare providers: Partnerships between manufacturers and healthcare providers facilitate the implementation of POC diagnostics in clinical settings.
- Government support: Initiatives like the WHO's "Assure" program support the development and distribution of affordable POC diagnostics in developing countries.
Market Segmentation: Infectious Disease Point-of-care (POC) Diagnostics Analysis
By Technique:
- Lateral Flow Immunoassay
- Agglutination Test
- Others
By Disease:
- HIV
- Hepatitis B Virus
- Pneumonia/Streptococcus Associated Infections
- RSV
- Influenza
- Clostridium Difficile Infections
- Hepatitis C Virus
- Methicillin-Resistant Staphylococcus Aureus
- Tuberculosis
- Others
By COVID-19 Point-of-care:
- POC
By End User:
- Hospital Bedside
- Physicians Office Lab
- Urgent Care & Retail Clinics
- Others
Leading Players in the Infectious Disease Point-of-care (POC) Diagnostics Market
- F. Hoffmann-La Roche Ltd (Switzerland)
- Thermo Fisher Scientific Inc. (U.S.)
- Abbott Laboratories (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- BD (U.S.)
- bioMérieux SA (France)
- Cardinal Health, Inc. (U.S.)
- Cepheid (U.S.)
- Trinity Biotech (Ireland)
- Quidel Corporation (U.S.)
- Bio-Rad Laboratories Inc. (U.S)
Significant developments in Infectious Disease Point-of-care (POC) Diagnostics Sector
- January 2023: Cipla Inc. launched a point-of-care testing device, Cippoint.
- February 2022: Trinity Biotech received approval for its TrinScreen HIV from the WHO.
- October 2021: Hologic, Inc. announced the launch of the Aptima SARS-CoV-2/Flu Assay.
- April 2021: Chembio Diagnostics, Inc. announced the launch of the rapid point-of-care COVID-19 /Flu A&B test.
- March 2021: Roche announced the launch of Cobas SARS-CoV-2 Variant Set 1 Test.
Comprehensive Coverage Infectious Disease Point-of-care (POC) Diagnostics Market Report
Our updated report provides a comprehensive and in-depth analysis of the global Infectious Disease Point-of-care (POC) Diagnostics Market, delivering:
- Market Sizing and Forecasting: Precise estimations of current market value and projections of future growth, segmented by technology, application, and geography.
- Detailed Regional and Country-Level Analysis: A granular examination of market dynamics across key regions and countries, identifying high-growth areas and potential market opportunities.
- Competitive Landscape Analysis: In-depth profiles of leading players, their market share, competitive strategies, recent partnerships, and mergers & acquisitions.
- Technological Landscape Analysis: Evaluation of current and emerging technologies, including their strengths, weaknesses, and potential for future growth.
- Growth Drivers and Market Challenges: A comprehensive assessment of factors driving market growth, alongside an identification and analysis of potential barriers and challenges.
- Regulatory Landscape Analysis: A review of the regulatory environment and its impact on market growth and access to POC diagnostic technologies.
- Investment Opportunities and Market Potential: Identification of promising investment opportunities and assessment of the overall market potential for various stakeholders.
Regional Insight
-
North America:
- Dominant market position due to advanced healthcare infrastructure, high healthcare spending, and presence of leading medical device manufacturers.
- Increased demand for rapid and accurate POC diagnostics for infectious disease management.
-
Europe:
- Strong government initiatives focused on healthcare modernization and patient-centered care.
- Prominent healthcare systems and a growing emphasis on personalized medicine.
- Rising prevalence of infectious diseases, particularly in developing countries within the region.
-
Asia-Pacific:
- Significant market expansion potential due to increasing healthcare expenditure, rising infectious disease burden, and government support for healthcare infrastructure development.
- Growing middle class with increased healthcare awareness and demand for improved healthcare.
-
Latin America:
- Rising demand for accessible and affordable healthcare services.
- Increased healthcare awareness and government initiatives aimed at improving healthcare access.
- Challenges related to healthcare infrastructure and resource allocation in certain regions.
-
Middle East and Africa:
- Growing investment in healthcare infrastructure and medical technologies.
- High prevalence of infectious diseases, particularly in developing countries within the region.
- Need for innovative and affordable POC diagnostics to address healthcare challenges in remote and under-resourced areas.
Pricing Analysis
- Product Benchmarking
- Price Analysis by Region
- Price trends over time
Import And Export Analysis
- Import and export data by country
- Analysis of trade dynamics
- Identification of major trading partners
Segmentation
- Market segmentation by technique, disease, end-user, and region
- Analysis of each segment's contribution to the market
- Market share analysis by segment
Patent/Trademark Analysis
- Analysis of patents and trademarks related to Infectious Disease POC Diagnostics
- Identification of key patent holders and innovators
- Market impact of IP protection
Infectious Disease Point-of-care (POC) Diagnostics Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 6.5% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Introduction of Cost-effective Manufacturing Processes to Drive Market Growth
- 3.3. Market Restrains
- 3.3.1. Lack of Accuracy Associated with Point-of-care Diagnostics Tests to Reduce Product Adoption
- 3.4. Market Trends
- 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Infectious Disease Point-of-care (POC) Diagnostics Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Technique
- 5.1.1. Lateral Flow Immunoassay
- 5.1.2. Agglutination Test
- 5.1.3. Others
- 5.2. Market Analysis, Insights and Forecast - by Disease
- 5.2.1. HIV
- 5.2.2. Hepatitis B Virus
- 5.2.3. Pneumonia/Streptococcus Associated Infections
- 5.2.4. RSV
- 5.2.5. Influenza
- 5.2.6. Clostridium Difficile Infections
- 5.2.7. Hepatitis C Virus
- 5.2.8. Methicillin-Resistant Staphylococcus Aureus
- 5.2.9. Tuberculosis
- 5.2.10. Others
- 5.3. Market Analysis, Insights and Forecast - by Disease, COVID-19 Point-of-care
- 5.3.1. POC
- 5.4. Market Analysis, Insights and Forecast - by End User
- 5.4.1. Hospital Bedside
- 5.4.2. Physicians Office Lab
- 5.4.3. Urgent Care & Retail Clinics
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast - by Region
- 5.5.1. By Geography
- 5.1. Market Analysis, Insights and Forecast - by Technique
- 6. North America Infectious Disease Point-of-care (POC) Diagnostics Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 6.1.1 United States
- 6.1.2 Canada
- 6.1.3 Mexico
- 7. South America Infectious Disease Point-of-care (POC) Diagnostics Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.1.1 Brazil
- 7.1.2 Argentina
- 7.1.3 Rest of South America
- 8. Europe Infectious Disease Point-of-care (POC) Diagnostics Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.1.1 Germany
- 8.1.2 France
- 8.1.3 Italy
- 8.1.4 United Kingdom
- 8.1.5 Netherlands
- 8.1.6 Rest of Europe
- 9. Europe Infectious Disease Point-of-care (POC) Diagnostics Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.1.1 Germany
- 9.1.2 France
- 9.1.3 Italy
- 9.1.4 United Kingdom
- 9.1.5 Netherlands
- 9.1.6 Rest of Europe
- 10. MEA Infectious Disease Point-of-care (POC) Diagnostics Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.1.1 Middle East
- 10.1.2 Africa
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2024
- 11.2. Company Profiles
- 11.2.1 F. Hoffmann-La Roche Ltd (Switzerland)
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Thermo Fisher Scientific Inc. (U.S.)
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Abbott Laboratories (U.S.)
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Quest Diagnostics Incorporated (U.S.)
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 BD (U.S.)
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 bioMérieux SA (France)
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Cardinal Health Inc. (U.S.)
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Cepheid (U.S.)
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Trinity Biotech (Ireland)
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Quidel Corporation (U.S.)
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Bio-Rad Laboratories Inc. (U.S)
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.1 F. Hoffmann-La Roche Ltd (Switzerland)
List of Figures
- Figure 1: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue Breakdown (USD Billion, %) by Region 2024 & 2032
- Figure 2: Global Infectious Disease Point-of-care (POC) Diagnostics Market Volume Breakdown (K Units, %) by Region 2024 & 2032
- Figure 3: North America Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion), by Country 2024 & 2032
- Figure 4: North America Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units), by Country 2024 & 2032
- Figure 5: North America Infectious Disease Point-of-care (POC) Diagnostics Market Revenue Share (%), by Country 2024 & 2032
- Figure 6: North America Infectious Disease Point-of-care (POC) Diagnostics Market Volume Share (%), by Country 2024 & 2032
- Figure 7: South America Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion), by Country 2024 & 2032
- Figure 8: South America Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units), by Country 2024 & 2032
- Figure 9: South America Infectious Disease Point-of-care (POC) Diagnostics Market Revenue Share (%), by Country 2024 & 2032
- Figure 10: South America Infectious Disease Point-of-care (POC) Diagnostics Market Volume Share (%), by Country 2024 & 2032
- Figure 11: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion), by Country 2024 & 2032
- Figure 12: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units), by Country 2024 & 2032
- Figure 13: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Revenue Share (%), by Country 2024 & 2032
- Figure 14: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Volume Share (%), by Country 2024 & 2032
- Figure 15: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion), by Country 2024 & 2032
- Figure 16: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units), by Country 2024 & 2032
- Figure 17: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Revenue Share (%), by Country 2024 & 2032
- Figure 18: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Volume Share (%), by Country 2024 & 2032
- Figure 19: MEA Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion), by Country 2024 & 2032
- Figure 20: MEA Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units), by Country 2024 & 2032
- Figure 21: MEA Infectious Disease Point-of-care (POC) Diagnostics Market Revenue Share (%), by Country 2024 & 2032
- Figure 22: MEA Infectious Disease Point-of-care (POC) Diagnostics Market Volume Share (%), by Country 2024 & 2032
- Figure 23: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion), by Technique 2024 & 2032
- Figure 24: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units), by Technique 2024 & 2032
- Figure 25: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Revenue Share (%), by Technique 2024 & 2032
- Figure 26: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Volume Share (%), by Technique 2024 & 2032
- Figure 27: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion), by Disease 2024 & 2032
- Figure 28: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units), by Disease 2024 & 2032
- Figure 29: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Revenue Share (%), by Disease 2024 & 2032
- Figure 30: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Volume Share (%), by Disease 2024 & 2032
- Figure 31: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion), by Disease, COVID-19 Point-of-care 2024 & 2032
- Figure 32: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units), by Disease, COVID-19 Point-of-care 2024 & 2032
- Figure 33: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Revenue Share (%), by Disease, COVID-19 Point-of-care 2024 & 2032
- Figure 34: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Volume Share (%), by Disease, COVID-19 Point-of-care 2024 & 2032
- Figure 35: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion), by End User 2024 & 2032
- Figure 36: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units), by End User 2024 & 2032
- Figure 37: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Revenue Share (%), by End User 2024 & 2032
- Figure 38: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Volume Share (%), by End User 2024 & 2032
- Figure 39: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion), by Country 2024 & 2032
- Figure 40: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units), by Country 2024 & 2032
- Figure 41: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Revenue Share (%), by Country 2024 & 2032
- Figure 42: By Geography Infectious Disease Point-of-care (POC) Diagnostics Market Volume Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue USD Billion Forecast, by Region 2019 & 2032
- Table 2: Global Infectious Disease Point-of-care (POC) Diagnostics Market Volume K Units Forecast, by Region 2019 & 2032
- Table 3: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue USD Billion Forecast, by Technique 2019 & 2032
- Table 4: Global Infectious Disease Point-of-care (POC) Diagnostics Market Volume K Units Forecast, by Technique 2019 & 2032
- Table 5: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue USD Billion Forecast, by Disease 2019 & 2032
- Table 6: Global Infectious Disease Point-of-care (POC) Diagnostics Market Volume K Units Forecast, by Disease 2019 & 2032
- Table 7: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue USD Billion Forecast, by Disease, COVID-19 Point-of-care 2019 & 2032
- Table 8: Global Infectious Disease Point-of-care (POC) Diagnostics Market Volume K Units Forecast, by Disease, COVID-19 Point-of-care 2019 & 2032
- Table 9: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue USD Billion Forecast, by End User 2019 & 2032
- Table 10: Global Infectious Disease Point-of-care (POC) Diagnostics Market Volume K Units Forecast, by End User 2019 & 2032
- Table 11: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue USD Billion Forecast, by Region 2019 & 2032
- Table 12: Global Infectious Disease Point-of-care (POC) Diagnostics Market Volume K Units Forecast, by Region 2019 & 2032
- Table 13: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue USD Billion Forecast, by Country 2019 & 2032
- Table 14: Global Infectious Disease Point-of-care (POC) Diagnostics Market Volume K Units Forecast, by Country 2019 & 2032
- Table 15: United States Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 16: United States Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 17: Canada Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 18: Canada Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 19: Mexico Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 20: Mexico Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 21: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue USD Billion Forecast, by Country 2019 & 2032
- Table 22: Global Infectious Disease Point-of-care (POC) Diagnostics Market Volume K Units Forecast, by Country 2019 & 2032
- Table 23: Brazil Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 24: Brazil Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 25: Argentina Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 26: Argentina Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 27: Rest of South America Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 28: Rest of South America Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 29: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue USD Billion Forecast, by Country 2019 & 2032
- Table 30: Global Infectious Disease Point-of-care (POC) Diagnostics Market Volume K Units Forecast, by Country 2019 & 2032
- Table 31: Germany Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 32: Germany Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 33: France Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 34: France Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 35: Italy Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 36: Italy Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 37: United Kingdom Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 38: United Kingdom Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 39: Netherlands Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 40: Netherlands Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 41: Rest of Europe Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 42: Rest of Europe Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 43: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue USD Billion Forecast, by Country 2019 & 2032
- Table 44: Global Infectious Disease Point-of-care (POC) Diagnostics Market Volume K Units Forecast, by Country 2019 & 2032
- Table 45: Germany Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 46: Germany Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 47: France Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 48: France Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 49: Italy Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 50: Italy Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 51: United Kingdom Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 52: United Kingdom Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 53: Netherlands Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 54: Netherlands Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 55: Rest of Europe Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 56: Rest of Europe Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 57: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue USD Billion Forecast, by Country 2019 & 2032
- Table 58: Global Infectious Disease Point-of-care (POC) Diagnostics Market Volume K Units Forecast, by Country 2019 & 2032
- Table 59: Middle East Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 60: Middle East Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 61: Africa Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 62: Africa Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 63: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue USD Billion Forecast, by Technique 2019 & 2032
- Table 64: Global Infectious Disease Point-of-care (POC) Diagnostics Market Volume K Units Forecast, by Technique 2019 & 2032
- Table 65: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue USD Billion Forecast, by Disease 2019 & 2032
- Table 66: Global Infectious Disease Point-of-care (POC) Diagnostics Market Volume K Units Forecast, by Disease 2019 & 2032
- Table 67: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue USD Billion Forecast, by Disease, COVID-19 Point-of-care 2019 & 2032
- Table 68: Global Infectious Disease Point-of-care (POC) Diagnostics Market Volume K Units Forecast, by Disease, COVID-19 Point-of-care 2019 & 2032
- Table 69: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue USD Billion Forecast, by End User 2019 & 2032
- Table 70: Global Infectious Disease Point-of-care (POC) Diagnostics Market Volume K Units Forecast, by End User 2019 & 2032
- Table 71: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue USD Billion Forecast, by Country 2019 & 2032
- Table 72: Global Infectious Disease Point-of-care (POC) Diagnostics Market Volume K Units Forecast, by Country 2019 & 2032
- Table 73: North America Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 74: North America Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 75: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 76: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 77: Asia Pacific Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 78: Asia Pacific Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 79: Latin America Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 80: Latin America Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
- Table 81: Middle East & Africa Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 82: Middle East & Africa Infectious Disease Point-of-care (POC) Diagnostics Market Volume (K Units) Forecast, by Application 2019 & 2032
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.
Frequently Asked Questions
2. Which companies are prominent players in the Infectious Disease Point-of-care (POC) Diagnostics Market?
Key companies in the market include F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Abbott Laboratories (U.S.), Quest Diagnostics Incorporated (U.S.), BD (U.S.), bioMérieux SA (France), Cardinal Health, Inc. (U.S.), Cepheid (U.S.), Trinity Biotech (Ireland), Quidel Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S).
3. What are the main segments of the Infectious Disease Point-of-care (POC) Diagnostics Market?
The market segments include Technique, Disease, Disease, COVID-19 Point-of-care, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 15.81 USD Billion as of 2022.
5. What are some drivers contributing to market growth?
Introduction of Cost-effective Manufacturing Processes to Drive Market Growth.
6. What are the notable trends driving market growth?
Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.
7. Are there any restraints impacting market growth?
Lack of Accuracy Associated with Point-of-care Diagnostics Tests to Reduce Product Adoption.
8. Can you provide examples of recent developments in the market?
January 2023 - Cipla Inc. launched a point-of-care testing device, Cippoint. The device is CE IVD-approved and helps diagnose non-communicable and infectious diseases.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4850, USD 5850, and USD 6850 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in USD Billion and volume, measured in K Units.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Infectious Disease Point-of-care (POC) Diagnostics Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Infectious Disease Point-of-care (POC) Diagnostics Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Infectious Disease Point-of-care (POC) Diagnostics Market?
To stay informed about further developments, trends, and reports in the Infectious Disease Point-of-care (POC) Diagnostics Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.